AptamiR Therapeutics, Inc.
Develops therapies targeting fat accumulation, inflammation, and necrosis to treat obesity, dyslipidemia, diabetes and MAFLD while avoiding effects on brain function and improving patients' quality of life.
Employees
loading...
Funding Status
loading...
Established
loading...
Total Funding
loading...
ARR
loading...
Insights
Loading Insights...
Loading Insight content to display...
Loading Insights...
Loading Insight content to display...
Founders
loading...
Notable Customers
loading...
Funding
Workforce
Functional Distribution
N/A
Open Positions
N/A
Diversity
N/A